Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Munoz

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2017
Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose-effectCesare Cozzarini, Tiziana Rancati, Federica Palorini, et al.
Medical Oncology (Northwood, London, England)|April 23, 2013
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)Umberto Ricardi, Patrizia Racca, Pierfrancesco Franco, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter studyVittorio Vavassori, Claudio Fiorino, Tiziana Rancati, et al.
La Radiologia Medica|January 16, 2014
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatmentFrancesco Moretto, Monica Rampino, Fernando Munoz, et al.
Technology in Cancer Research & Treatment|July 15, 2010
Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imagingMarco Krengli, Barbara Cannillo, Lucia Turri, et al.
Cancer Investigation|December 20, 2014
Three-dimensional ultrasound-based image-guided hypofractionated radiotherapy for intermediate-risk prostate cancer: results of a consecutive case seriesUmberto Ricardi, Pierfrancesco Franco, Fernando Munoz, et al.
Cancer Investigation|May 8, 2015
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case seriesPierfrancesco Franco, Massimiliano Mistrangelo, Francesca Arcadipane, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRTRiccardo Valdagni, Tiziana Rancati, Claudio Fiorino, et al.
Cancer Treatment Reviews|March 20, 2021
Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Fernando Munoz, Francesco Fiorica, Luciana Caravatta, et al.
Surgical Endoscopy|January 25, 2021
Diagnosis of COVID-19 and the bariatric surgery population: a single center experienceGustavo Romero-Velez, Xavier Pereira, John Paul Skendelas, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 23, 2017
Patient-reported urinary incontinence after radiotherapy for prostate cancer: Quantifying the dose-effectCesare Cozzarini, Tiziana Rancati, Federica Palorini, et al.
Medical Oncology (Northwood, London, England)|April 23, 2013
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)Umberto Ricardi, Patrizia Racca, Pierfrancesco Franco, et al.
International Journal of Radiation Oncology, Biology, Physics|January 24, 2007
Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter studyVittorio Vavassori, Claudio Fiorino, Tiziana Rancati, et al.
La Radiologia Medica|January 16, 2014
Conventional 2D (2DRT) and 3D conformal radiotherapy (3DCRT) versus intensity-modulated radiotherapy (IMRT) for nasopharyngeal cancer treatmentFrancesco Moretto, Monica Rampino, Fernando Munoz, et al.
Technology in Cancer Research & Treatment|July 15, 2010
Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imagingMarco Krengli, Barbara Cannillo, Lucia Turri, et al.
Cancer Investigation|December 20, 2014
Three-dimensional ultrasound-based image-guided hypofractionated radiotherapy for intermediate-risk prostate cancer: results of a consecutive case seriesUmberto Ricardi, Pierfrancesco Franco, Fernando Munoz, et al.
Cancer Investigation|May 8, 2015
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case seriesPierfrancesco Franco, Massimiliano Mistrangelo, Francesca Arcadipane, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 2008
Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRTRiccardo Valdagni, Tiziana Rancati, Claudio Fiorino, et al.
Cancer Treatment Reviews|March 20, 2021
Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Fernando Munoz, Francesco Fiorica, Luciana Caravatta, et al.
Surgical Endoscopy|January 25, 2021
Diagnosis of COVID-19 and the bariatric surgery population: a single center experienceGustavo Romero-Velez, Xavier Pereira, John Paul Skendelas, et al.
Pageof 8